| NCT Number | NCT03422198 |
| Lead Sponsor | University of Utah
Collaborators: Huntsman Cancer Institute |
| Conditions | Endometrial Clear Cell Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage I Uterine Corpus Cancer, Stage IA Uterine Corpus Cancer, Stage IB Uterine Corpus Cancer, Stage II Uterine Corpus Cancer, Uterine Corpus Carcinosarcoma +1 more |
| Enrollment | 188 participants |
| Start Date | 2018-02-02 |
| Primary Completion | 2026-11-30 (estimated) |
| Study Completion | 2029-10-31 (estimated) |
| Updated on ClinicalTrials.gov | 2025-12-12 |